Sunshine Biopharma Inc (SBFM)

Jun 13, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 3.8% – Here’s Why - Defense World

Jun 13, 2025

Jun 12, 2025

Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’ - MSN

Jun 12, 2025

Jun 11, 2025

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic P - GuruFocus

Jun 11, 2025

Jun 11, 2025

Sunshine Biopharma launches generic anticonvulsant drug in Canada By Investing.com - Investing.com South Africa

Jun 11, 2025

Jun 11, 2025

Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’ By Stocktwits - Investing.com India

Jun 11, 2025

Jun 11, 2025

Sunshine Biopharma (SBFM) Expands Portfolio with New Gabapentin Launch | SBFM Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

Sunshine Biopharma launches generic anticonvulsant drug in Canada - Investing.com

Jun 11, 2025

Jun 11, 2025

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market - Yahoo Finance

Jun 11, 2025

Jun 11, 2025

Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees 'Huge Potential' - MENAFN.com

Jun 11, 2025

May 22, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading 17.8% Higher – Here’s Why - Defense World

May 22, 2025

May 20, 2025

Sunshine Biopharma Sees 18% Revenue Growth in Q1 2025 - TipRanks

May 20, 2025

May 16, 2025

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues - GuruFocus

May 16, 2025

May 15, 2025

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year - ACCESS Newswire

May 15, 2025

May 15, 2025

Sunshine Biopharma Reports Double-Digit Growth: Q1 Revenue Jumps 18% as Pipeline Expands with 6 New Drugs - Stock Titan

May 15, 2025

May 13, 2025

Sunshine Biopharma (NASDAQ:SBFM) Stock Price Up 8% – Here’s Why - Defense World

May 13, 2025

May 06, 2025

Sunshine Biopharma launches generic antipsychotic drug - Investing.com Australia

May 06, 2025

May 06, 2025

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia - GuruFocus

May 06, 2025

May 06, 2025

Sunshine Biopharma (SBFM) Unveils Generic Antipsychotic Drug in Canada | SBFM Stock News - GuruFocus

May 06, 2025

May 06, 2025

Sunshine Biopharma launches generic antipsychotic drug By Investing.com - Investing.com Canada

May 06, 2025

May 06, 2025

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market - ACCESS Newswire

May 06, 2025

May 06, 2025

Sunshine Biopharma Challenges $1.2B Antipsychotic Market With New Generic Latuda Alternative - Stock Titan

May 06, 2025

May 04, 2025

Certain Warrants of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 4-MAY-2025. - marketscreener.com

May 04, 2025

Apr 28, 2025

Sunshine Biopharma Inc’s Market Journey: Closing Weak at 1.84, Down -18.22 - DWinneX

Apr 28, 2025

Apr 26, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Stock Price Down 4.5% – Here’s Why - Defense World

Apr 26, 2025

Apr 24, 2025

There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - Sete News

Apr 24, 2025

Apr 23, 2025

Sunshine Becomes Latest To Compete On Everolimus In Canada - insights.citeline.com

Apr 23, 2025

Apr 22, 2025

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug - Asianet Newsable

Apr 22, 2025

Apr 21, 2025

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug By Stocktwits - Investing.com India

Apr 21, 2025

Apr 21, 2025

SBFM Stock: A Comprehensive Analysis and Forecast - investchronicle.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma enters Canadian generic drug market with Everolimus By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025

Apr 21, 2025

SBFM’s valuation metrics: A comprehensive analysis - uspostnews.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma (SBFM) Finalizes $2.46 Million Stock Offering - GuruFocus

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market - marketscreener.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma enters Canadian generic drug market with Everolimus - Investing.com

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada | SBFM Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | SBFM Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Major Cancer Treatment Everolimus Enters Canadian Market: Multiple Cancer Types Targeted in $2.5B Opportunity - Stock Titan

Apr 21, 2025

Apr 21, 2025

Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada - GuruFocus

Apr 21, 2025

Apr 16, 2025

Sunshine Biopharma stock hits 52-week low at $1.24 - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

Sunshine Biopharma stock hits 52-week low at $1.24 By Investing.com - Investing.com India

Apr 16, 2025

Apr 04, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 10.9% – Here’s Why - Defense World

Apr 04, 2025

Apr 03, 2025

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Closes $2.46 Million Direct Offering - TipRanks

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener

Apr 03, 2025

Apr 03, 2025

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire

Apr 03, 2025